Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants.
Cicconi L, Testi AM, Montesinos P, Rego E, Zhu HH, Takahashi H, Dworzak M, Estey E, Schwarer A, Esteve J, Annibali O, Castelli R, Mirabile M, Angelini M, Lazarevic V, Kumar J, Avvisati G, Gurnari C, Locatelli F, Voso MT, Sanz MA, Lo-Coco F, Abla O. Cicconi L, et al. Among authors: zhu hh. Blood Cancer J. 2021 Oct 16;11(10):167. doi: 10.1038/s41408-021-00561-w. Blood Cancer J. 2021. PMID: 34657125 Free PMC article. No abstract available.
The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission.
Huang XJ, Zhu HH, Chang YJ, Xu LP, Liu DH, Zhang XH, Jiang B, Jiang Q, Jiang H, Chen YH, Chen H, Han W, Liu KY, Wang Y. Huang XJ, et al. Among authors: zhu hh. Blood. 2012 Jun 7;119(23):5584-90. doi: 10.1182/blood-2011-11-389809. Epub 2012 Apr 24. Blood. 2012. PMID: 22535659 Free article. Clinical Trial.
Hyperthermia Selectively Destabilizes Oncogenic Fusion Proteins.
Maimaitiyiming Y, Wang QQ, Yang C, Ogra Y, Lou Y, Smith CA, Hussain L, Shao YM, Lin J, Liu J, Wang L, Zhu Y, Lou H, Huang Y, Li X, Chang KJ, Chen H, Li H, Huang Y, Tse E, Sun J, Bu N, Chiou SH, Zhang YF, Hua HY, Ma LY, Huang P, Ge MH, Cao FL, Cheng X, Sun H, Zhou J, Vasliou V, Xu P, Jin J, Bjorklund M, Zhu HH, Hsu CH, Naranmandura H. Maimaitiyiming Y, et al. Among authors: zhu hh, zhu y. Blood Cancer Discov. 2021 May 11;2(4):388-401. doi: 10.1158/2643-3230.BCD-20-0188. eCollection 2021 Jul. Blood Cancer Discov. 2021. PMID: 34661159 Free PMC article.
Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.
Wang H, Yang C, Shi T, Zhang Y, Qian J, Wang Y, Hu Y, Mao L, Ye X, Liu F, Xi Z, Shou L, Fu C, Naranmandura H, Jin J, Zhu HH. Wang H, et al. Among authors: zhu hh. Blood Cancer J. 2022 Jan 28;12(1):20. doi: 10.1038/s41408-022-00621-9. Blood Cancer J. 2022. PMID: 35091541 Free PMC article. No abstract available.
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial).
Wang HY, Gong S, Li GH, Yao YZ, Zheng YS, Lu XH, Wei SH, Qin WW, Liu HB, Wang MC, Xi JY, Chen LM, Zhang M, Zhang XX, Zhang HY, Zhang CS, Wald DN, Zhu HH, Liu L, He PC. Wang HY, et al. Among authors: zhu hh. Blood Cancer J. 2022 Nov 21;12(11):158. doi: 10.1038/s41408-022-00753-y. Blood Cancer J. 2022. PMID: 36404343 Free PMC article. Clinical Trial.
Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Xie M, Shi T, Jiang Q, Jia Y, Zhou D, Tong H, Jin J, Zhu HH. Xie M, et al. Among authors: zhu hh. Cancer. 2023 May 15;129(10):1523-1536. doi: 10.1002/cncr.34710. Epub 2023 Mar 7. Cancer. 2023. PMID: 36882308 Free article.
482 results